LMR Partners’s Precision BioSciences DTIL Stock Holding History

LMR Partners’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-601	Closed	-$23K	–	1155
2022 Q3	$23K	Hold	601	–	–	﹤0.01%	1150
2022 Q2	$29K	Buy	+601	New	+$35.3K	﹤0.01%	1207

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LMR Partners's DTIL Position: Q4 2022 in Review

LMR Partners sold out of Precision BioSciences (DTIL) in Q4 2022, closing a stake of 601 shares — an estimated $23K sold.

LMR Partners first reported a position in DTIL in Q2 2022 and held it in 2 quarters. The position peaked at $29K in Q2 2022. 100 funds tracked by Wall St. Rank hold DTIL as of Q4 2022.

LMR Partners reported no remaining Precision BioSciences position as of Q4 2022 after selling out during the quarter.
LMR Partners sold 601 Precision BioSciences shares in Q4 2022, an estimated $23K.
LMR Partners first reported a position in Precision BioSciences in Q2 2022 and held it in 2 quarters.
LMR Partners's Precision BioSciences position peaked at $29K in Q2 2022.
100 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2022.

Based on LMR Partners's 13F filing for Q4 2022, filed 14 Feb 2023.